The 8 analysts offering 12-month price forecasts for BELLUS Health Inc have a median target of 20.00, with a high estimate of 24.00 and a low estimate of 12.05. The median estimate represents a +154.78% increase from the last price of 7.85.
The current consensus among 8 polled investment analysts is to Buy stock in BELLUS Health Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.20
Reporting Date Feb 22
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.